Guidelines for the probabilistic treatment of community-acquired pneumonia: Compared experience between internal medicine and emergency departments in the University Hospital of Besancon, France

Affiliation auteurs!!!! Error affiliation !!!!
TitreGuidelines for the probabilistic treatment of community-acquired pneumonia: Compared experience between internal medicine and emergency departments in the University Hospital of Besancon, France
Type de publicationJournal Article
Year of Publication2014
AuteursGil H., Grenier F., Leroy J., Tisserand G., Meaux-Ruault N., Magy-Bertrand N.
JournalREVUE DE MEDECINE INTERNE
Volume35
Pagination231–234
Date PublishedAPR
Type of ArticleArticle
ISSN0248-8663
Mots-clésC-reactive protein, Community-acquired pneumonia, guidelines
Résumé

Introduction. - The objective of this study was to assess the application of local and national recommendations in the management of community-acquired pneumonia in an internal medicine department with an antibiotic referent physician and in an emergency department. Patients and methods. - This was a retrospective single-center study including patients admitted with community-acquired pneumonia in the internal medicine department of the University Hospital of Besancon after an initial admission in the emergency department. Results. - One hundred patients (58 women and 42 men) were included. The mean age was 79 +/- 11 years. The prescriptions done in the emergency department were in accordance with local recommendations or Societe de pathologie infectieuse de langue francaise (SPILF) recommendations in 62% of cases. The prescriptions followed the recommendations in 94% of cases in internal medicine department (P<0.05). The lack of initial antibiotic treatment had no influence on morbidity and mortality. Conclusion. The guidelines for infectious diseases treatment were significantly more often applied in a department where a referent physician was designated for this. (C) 2013 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

DOI10.1016/j.revmed.2013.03.001